BackSoligenix- Warrants (07/12/2021) Overview

Soligenix- Warrants (07/12/2021) Total Liabilities

Track Soligenix- Warrants (07/12/2021)'s total liabilities ($3.9M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$3.85M
↓ 1.98% YoYΔ $-77783.00 vs prior year quarter

Peer trimmed avg / median

Loading

Soligenix- Warrants (07/12/2021) Total Liabilities History

Loading

Soligenix- Warrants (07/12/2021) vs. peers: Total Liabilities Comparison

Loading

Soligenix- Warrants (07/12/2021) Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Soligenix- Warrants (07/12/2021) (SNGXW) FAQ

As of the most recent data (June 2026), SNGXW shows a total liabilities of $3.9M. That compares with $3.9M in the prior-year period — down 2.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SNGXW's total liabilities is now $3.9M (was $3.9M) — a 2.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Soligenix- Warrants (07/12/2021) is outperforming or lagging.

Tracking SNGXW's total liabilities over time shows whether Soligenix- Warrants (07/12/2021) is scaling, shrinking, or reshaping that part of the business. The current reading is $3.9M That compares with $3.9M in the prior-year period — down 2.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Soligenix- Warrants (07/12/2021)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $3.9M) with ownership activity and broader fundamentals.

Soligenix- Warrants (07/12/2021)'s total liabilities is $3.9M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.